Meeting with the MHRA regarding future surveillance of women taking valproate

Bromley, R. (Other)

Division of Evolution, Infection and Genomics

Activity: Internal positions, CPD, programme/unit design, other peer review and other › Other › Research

Description

The UK medications regulator the MHRA invited experts to consult on the establishing of a register to monitor the continued but restricted use of sodium valproate in women of childbearing age and the longer term outcome of the children exposed to that medication in the womb.

Period	2018 → 2019

Keywords

Regulation
Teratology
Epilepsy
Pregnancy
Anti epileptic drugs
Neurodevelopment